« Back to slide 1
Continue to slide 3 »

#9. QCLN — THREE MONTH RETURN = -25.30%

Company Name:  First Trust Exchange-Traded Fund - NYSE Arca Biotechnology Index Fund
Sector:  ETFs & CEFs

First Trust NYSE Arca Biotechnology Index Fund is an open-end management company. The Fund seeks investment results that correspond generally to the price and yield of an equity index called the NYSE Arca Biotechnology Index (the Index). The Index is an equal dollar-weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. As of Dec 31 2013, the Fund's total assets were $983,610,857 and the Fund's investment portfolio was valued at $969,483,653.

« Back to slide 1
Continue to slide 3 »
Quiz: Are You Ready To Invest In Stocks?
Famous Investing Quotes To Live By
The 15 Largest Companies In America
24 Growth Stocks For '24
16 Cheap Stock Gambles Under $10
5 Stocks On Fire Since Five Years Ago
10 Stocks That Grew $10K To $100K+
20 Stocks That Delivered For 20 Years
11 Dividend Champions Poised To Pop
The 10 Best Dow Stocks
Real Estate With Upside: 20 Stock Picks
5 'Coffee Can Stocks' Led To Riches
Eye-Popping Real Estate Yields
10 ETFs Getting Slammed
5 Toxic Stocks Analysts Hate
15 Stock Leaders Since 2018
14 Tech Stocks To Buy Now
17 Investments with a Conscience
Energy Stocks To Power Your Portfolio
10 Five-Year Stock Gold Mines
The Five S&P 500 10-Year Monsters
10 Stocks I Wish You Bought 20 Years Ago
Heal Your Portfolio With Healthcare
2-Decade Stock Winners Since 2003
10 Financially Rewarding Financials
Ten Crazy-High Yielders
Mining $$$ With Metals Stocks
Swing-Trade These Highly Volatile Stocks
Fifteen Huge Winners Since 2013
ETFs on a Three Month Tear
Are You Ready To Beat The Market?
Quotes delayed 20 minutes
 

10 ETFs Getting Slammed - Page 2 | www.InvestHELP.net | Copyright © 2018 - 2023, All Rights Reserved

Nothing in InvestHELP.net is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.